Although breast implant materials have been tested in laboratory species since the early 1950s, a standardized evaluation system does not currently exist in which human-made polymers are exposed directly to the mammary milieu of female animals. The present study evaluated such a model as the basis for future experiments on long-term tissue effects. Polyesterurethane disks, 6 mm in diameter x 3 mm thick, were inserted bilaterally beneath the axillobrachial and inguinal mammary/fat pads of 50 9-wk-old female B6D2F, mice (4 implants each). Implant sites were examined histologically at time points 24 hr to 47 wk after surgery. An acute inflammatory reaction at the implant edges began within 24 hr, and macrophages were found lining the smooth polyurethane fiber surfaces at the periphery by day 2. Multinucleated foreign body giant cells formed by day 4, and by week 4 giant cells contained polyurethane fragments within the cytoplasm, implying degradation of the material. Implant sites showed declining subacute inflammatory responses and increasing fibrosis by week 5. By 13 wk, the polyurethane disks appeared to be integrated into the growing adipose and mammary tissues. Although not apparent on gross inspection, microscopic examination showed that polyurethane fibers moved progressively into adjacent tissues and were always associated with chronic granulomatous inflammation. Histologic findings in the present study are strikingly similar to the human response to polyurethane-coated breast implants. These results suggest the applicability of this model to appropriately test mammaplasty materials in mammary tissues.
INTRODUCTION
Hundreds of thousands of women have undergone breast augmentation or reconstruction using artificial implants (5, 11, 54) . The number of these procedures performed has decreased in recent years, probably due in part to the adverse publicity generated by more frequent reports of implant-associated health problems. Closer scientific scrutiny of such complaints has culminated in the recent Food and Drug Administration (FDA) restrictions on the use of silicone gel-filled artificial devices for breast reconstruction and augmentation (1 3). Implants coated with polyurethane (PU) foams accounted for a small but significant number of these devices until the 1980s and early 199Os, when several manufacturers began to voluntarily withdraw them from the market. This drop in demand may have been a result of both unfavorable clinical reactions (6,46,' 55,56) and the possibility of the release of toxic degradation products raised by in vitro experiments (3, 5, 14, (24) (25) (26) . No remaining manufacturer of PU-coated implants submitted the FDA-required safety data on their product prior to the July 199 1 filing deadline, in practice making this typeof device no longer . DEVORETAL TOXICOLOGIC PATHOLOGY ployed a consistent experimental system relevant to sex, anatomic site, and pertinent physiology. The majority of studies, both historical and current, appear to involve implantation to nonmammary sites, overwhelmingly performed in male animals and designed primarily to test tumorigenic effects (4,7,33, 34,47,49,5 1) . Ofthe studies performed with female animals, only 1, to our knowledge, involved placement of PU sponge specifically in the thoracic mammary pads of mice (22) . Furthermore, analysis of the early tissue reaction, i.e., within the first 4 wk of implantation, was rarely done in any implant study examined, although accounts of early complications to breast implants in women are not uncommon and often set the stage for ongoing problems (15, 29, 46, 52, 53, 55, 58) . The protocol described here allows for interim sampling of mammary implants and surrounding tissues in order to characterize and compare the continuum of tissue reactions to PU foam in the female mouse with those documented in human cases.
MATERIALS AND METHODS Sixty-five female (C57BL/6NCr x DBA/2NCr)F, (B6D2FJ mice were obtained from Frederick Cancer Research and Development Center (FCRDC) Animal Production Area (Frederick, MD) at the age of 4 wk and housed 5 per cage on hardwood chip bedding with autoclavable lab chow and tap water provided ad libittun. Husbandry and experimental procedures were in compliance with requirements set forth by the Public Health Service (PHS) Guide for the Care and Use of Laboratory Animals and the facility Animal Care and Use Committee. When the animals reached 9 wk of age, they were individually identified by means of coded ear punches. Two implant groups, comprised of 25 mice each, received 4 uniformly sized PU foam disks, 1 to each of the axillary and inguinal mammary pads; remaining control mice underwent sham operations. Using a standard 3-hole paper punch, the foam disks were cut from 1.5-mm-thick biomedical grade foam sheets (polyesterurethane grade 5-6, 199 1, Surgitek, Paso Robles, CA), doubled over to give a circular pad 3 mm thick x 6 mm in diameter. All disks were soaked overnight in 70% ethanol, followed by a minimum 1 hr rinse in sterile phosphate-buffered saline prior to implantation. Under methoxyflurane (Metofane, Pitman-Moore, Inc., Washington Crossing, NJ) anesthesia, mice were shaved dorsolaterally using electric clippers with a size 40 surgical blade, and loose hair particles were removed from the surgical sites by taping and repeated ethanol wipes. Four incisions slightly larger than the 3x -6-mm foam disks were made dorsally in the skin and subcutis just behind each scapula and slightly lateral and anterior to each hip joint ( Fig. 1) . A small pocket was made between the subcutaneous tissues and the underlying musculature using blunt dissection. The saline-saturated implants were inserted into the pocket beneath the mammary fat pad approximately 10 mm below the initial incision; in 1 group of 25, the incisions were closed with a single surgical wound clip (9-mm Autoclip, Clay Adams, Parsippany, NJ). The second group's incisions were closed using suture (Ethicon 6-0 non-absorbable silk, Ethicon, Inc., Somerville, NJ). Control mice were treated identically but did not receive implants. All mice recovered in clean cages under low-heat lamps. At least 2 implanted animals and a single control from each group were killed by CO, asphyxiation at 1, 2, 4, and 7 days and thereafter a 2, 3, 4, 13, 26, and 47 wk. Two additional implant-bearing animals were bred and allowed to raise litters to determine whether the foam inserts affected, or were affected by, mammary growth, maturation, or lactation. At each time point, the implant sites, with the foam disk in situ, were excised. Regional lymph nodes, spleen, and any gross lesions were also preserved. Tissues were fixed in 10% neutral-buffered formalin, processed, embedded in paraffin, and stained with hematoxylin and eosin (H&E), Masson's trichrome, phosphotungstic acid-hematoxylin (PTAH), Prussian blue, and acid fast. Additional samples were selected from the animals sacrificed at 4 wk for ultrastructural studies; these were fixed in a solution of 2.5% glutaraldehyde in 0.1 M cacodylate buffer at 4°C for 2 hr. Following post-fixation in 1% osmium tetroxide for 1 hr, they were stained with 0.5% uranyl acetate and embedded in epoxy resin. Thick sections were stained with Toluidine blue and thin sections with uranyl acetate and lead citrate.
RFSULTS

Gross Findings
Slight edema at the implantation site was the only grossly noticeable change for the first 72 hr postsurgery in both the sham controls and implanted animals. By day 4, when remaining wound clips yere removed, there was no indication of fluid accumulation in any of the animals examined, nor was edema a feature of subsequent microscopic evaluations. Complicating infection was not a factor in any of the treatment groups, and all incision sites were closed and healing well within 3 days, even in animals that had prematurely lost or removed their wound clips or sutures. The overall insert retention proved to be good; all 4 implants were retained in 36/50 (72%) of the cases, and only 2 animals (4%) lost 3 of the 4 foam disks. After the subsidence of the initial edema, the implants appeared to be clin- ically quiescent at all time points sampled. By the second or third week following surgery, autopsies revealed that the implants has assumed the same reddish coloration as the surrounding tissue and appeared well integrated at the implantation site, showing vascular and tissue ingrowth peripherally ( Fig. 2) . Removal of the implant at this time was not possible without some excision of tissue. At 13 wk, many of the implants were not apparent by gross visual inspection. Autopsy findings showed the disks had flattened and compressed considerably, although the diameter was about the same. or slightly less than at insertion. An encapsulating tissue mem: brane could not be discerned macroscopically.
There was no recognizable foam implant present 47 wk after implantation. All that remained at the implant site was a roughly circular thin smear of dark yellow to tan scar-like material, 4-7 mm in diameter, usually in the subcutis or adhered to the skin but occasionally attached to underlying muscle. Microscopically, the thickness was estimated to be no more than 250 pm. Implants taken at 26 wk from the 2 mice allowed to breed and nurse litters differed only in that the mammary pads were thicker and predictably more developed. The implants did not seem to affect either pregnancy or lactation as inferred from the litter sizes (average 10.5 pups), survival (100%), and health of the pups.
Microscopic Findings
PU foam, paraffin-embedded and stained prior to insertion as a reference, showed up as a network of sharply angular crystalline fibers, usually triangular or rectangular in shape with concave sides, interconnected by nebulous strands. Tendrils and blebs that tapered off the fiber edges and tips were another sh@&teristic feature (Fig. 3) . The fibers stained a typical pink w i h H&E but appeared a more distinctive red with acid fast, greenish with Masson's trichrome, and red-orange with PTAH.
Within 24 hr, there was a mild, diffuse infiltration into the implant site by neutrophils, with slight edema, hemorrhage, and fibrin deposition ( Fig. 4 ). vessels started to sprout and immature mesenchy-ma1 cells (fibroblasts) proliferated. By day 4 there was an influx of various inflammatory cells (neutrophils, plasma cells, histiocytes, and lymphocytes) into the area, and day 4 also marked the first appearance of multinucleated foreign body giant cells. Fibroblasts were now seen throughout the implant.
At 7 days post-implantation, macrophages were seen associated with fibers deep into the implant, multinucleated giant cells increased in size, fibroblasts matured into fibrocytes, and mature collagen was detectable forming a thin connective tissue capsule (Figs. 6 and 7).
Fibrocytes and collagen completely penetrated the disk by 2 wk post-implantation ( Fig. 8 ). This corresponded well to the compression and firmness noted on gross observation and palpation. Inflammatory cell aggregates also surrounded PU fibers at the centers of the foam disks, and central neovascularization was noted. The fibrous capsule of the implant periphery, while thickening and becoming more organized, was also incomplete in several areas. At capsule interruptions, which were even more striking at later time points, there were ingrowths of maturing adipose and mammary tissue and the first indications of PU fiber migration ( Fig. 9 ), probably mitigated by the release of lytic proteases from activated phagocytes. Focal lymphocytic aggregates surrounding capillaries developed occasionally in the capsule/foam periphery during the third wk. There was hemosiderin deposition and an increase in the numbers of lymphocytes, plasma cells, mast cells, and eosinophils. The encircling, collagenized tissue capsule contained isolated PU fibers as well as nests of adipose tissue and mammary glands ( Fig.  9 ). Capillaries throughout the implant were hyperemic. As time progressed, numbers and size of the foreign body cells increased (Fig. 10 ).
The first unequivocal ingestion of PU particles by giant cells was observed in animals sacrificed 4 wk after implantation (Fig. 11 ). Giant cells were apparently now capable of engulfing and phagocytosing the smaller blebs and laminated fibrils, previously noted as an inherent characteristic of the PU fibers ( Fig. 12) . Focal hemorrhages were also prewent, presumably caused by mechanical disruption of the newly formed capillaries from the movement of the PU fibers and/or surrounding tissues ( Fig. 10) .
Ultrastructurally, the PU fibers proved to be very unstable when exposed to the electron beam. Larger pieces ruptured immediately. Macrophages and foreign body giant cells showed numerous cytoplasmic extensions and vesicles in association with the PU (Figs. 13 and 14) . Occasionally an interruption of the PU fiber by a cell process was observed, resem- bling a cytoplasmic bridging or possible pinching off of a fragment by the giant cell (Fig. 14) .
The acute to subacute inflammatory response declined in intensity in the ensuing weeks but a chronic, granulomatous foreign body response persisted . There were also focal areas of proliferative lymphocytes noted through experimental week 47. Phagocytosis of PU particles was increasingly prevalent and now also included smaller triangular PU fibers ( Figs. 15 and 16) . A brownish green pigment was frequently seen in macrophages and giant cells (Fig. 17) ; this was identified as hemosiderin with Prussian blue staining and was also present in regional lymph nodes. PU implants taken from mice allowed to breed and nurse showed severe fibrosis and multifocally extensive fiber migration into surrounding tissue . PU fibers were found in close association with lactating mammary alveoli (Figs. 18 and 20) . Furthermore, it was apparent that fibers migrating outside the original im-..p,lp$also elicited a chronic foreign body response outside the origihal implant. Foreign body giant cells had attained their largest size at 26 wk post-implantation ( Fig. 19) . By week 47, individual PU fibers were seen scattered around the implant remnant, sequestered by a mantle of macrophages, giant cells, and connective tissue. At no time point was an impairment of normal mammary growth and development or of normal mammary function noted in the mice. Histologic features of the mammary ducts, alveoli, and adipose 
DISCUSSION
The animal model examined in the present study shows significant applicability for testing components of artificial mammary prosthetic and aug-xientation devices. Implantation to the major mammary pads takes into consideration the effects of hormonal rhythms and adjacent muscle movement. The procedure is feasible in many mammalian lab species and may prove practical in the study of both acute and long-term reactions in those animals considered susceptible (rat, mouse) or resistant (hamt Fig. 1 1. -Four wk post-implantation. Phagocytosis of a PU particle by a foreign body giant cell (arrow). Masson's trichromc. x 630. TOXICOLOGIC PATHOLQGY 6, 10, 12,38,46,55,56  6, 10,46,48,56  56  55,56  6, 15,24,38,46,55, 56  6, 18,46, 55  6, 12, 18,46,48  6,21,48  15. 38.46 a References pertain to findings in human case studies only.
ster, guinea pig) to foreign body carcinogenesis (8, 9, 50). The system also provides a means of investigating any promotional effects of implants. Dispersal, degradation, and metabolism of artificial materials can be assessed via local and distant tissues, blood, breast milk, lymph fluids, urine, and feces. Implantation to 4 sites increases the sample size per animal as well as per experimental group. The possible effects of placement, as mediated by blood or fat supply, can be compared in the same animal, and individual implants can easily be manipulated in terms of placement or experimental treatment. Implantation via the dorsal aspect allows for easy and accurate visual observation and palpation without having to handle the animals excessively, minimizing stress as well as possible trauma to the sites. There is also less chance of complicating wound infections through contact with dirty bedding. Finally, the procedure is rapid, inexpensive, technically uncomplicated, and well-tolerated by the animals. Only 2 mice were lost to anesthesia prior to completion of the implant procedure, but none died thereafter as a result of surgical complications.
What is known about human breast tissue responses to PU foam is provided by case histories of capsulectomies, capsulotomies, and implant removals. As Table I shows, all of the lesions observed in the present study have also been described in women bearing foam-enveloped implants and follow a basically parallel chronology. There are, naturally, differences between the human and mouse. Severe abscessing, edema, and hematoma formation have been reported in women at various time points after surgical insertion (1 5, 18,2 1) . The present study may have been too short or simplistic for such lesions to develop in mice; however, other ex-periments examining subcutaneous tissue reaction to PU in mice, rats, or rabbits for 1 yr and longer did not mention abscess, edema, or hematoma as major complications (10,22,4 1,49,50) . We suggest that, in the human, these sequelae are likely the result of individual immune status, surgical trauma/ contamination, the implant design, inadequate sterilization of the implant itself, or anatomical placement of the implant(s).
In addition to the similarities ofthe inflammatory response, there are several other facets of the PU bioreactivity question revealed by our mouse study. One is that clinical quiescence is not always indicative of biological inertness. It must be pointed out that the majority of human implant recipients are clinically problem-free. Nevertheless, a number of reports describe chronic subclinical and late-developing severe granulomatous inflammations. In our mice, individual PU fibers were still eliciting an inflammatory response in tissues outside the implant site 47 wk after surgery in all animals examined. Immune reaction to PU has been shown to be much more intense and persistent than that induced by silicone alone (50, 53, 62 ). This has been attributed to (a) foam fragmentation and fiber migration into surrounding tissues (6, 15, 38, 40, 48, 53, 55,  56) , (b) slow leaching of manufacturing contami nants (3, 27, 33, 49) , and (c) products released in chemical degradation (2,3,5, 14,20) . Whatever the cause, chronic overstimulation of the immune system has been postulated to lead to connective tissue disotders, and .migrating PU may spread inflammation beyond the implant site (3, 5,6, 19, 30,40,  53, 59, 62, 63) .
Another related aspect raised by this study is the fate of PU in viva The PU envelopes of breast imt Fig. 1 g.-Twenty-six (20, 29, 53, 5 5 , 56) . By 13 wk after insertion, our mouse implants showed size reductions. By 47 wk post-implantation, they were virtually gone. PU coverings of silicone gel-filled prostheses were devised to reduce fibrotic contractures that frequently occurred around a smooth-walled implant. Contractual forces were dispersed via collagenization of the foam pores; additionally, tissue growth into the foam helped to immobilize the device ( 5 , 6, 38, 46, 48) . However, it was discovered that this very process fragmented the envelope, which, in some cases, allowed formation of contractile fibrous capsules around the exposed smooth inner wall of the prostheses, negating the original purpose (10, 38, 55, 56) . The process also exposes more PU surface on which the body's inflammatory cell population, particularly macrophages, can work.
Phagocytosis of PU occurs in humans as well as in experimental animals (3, 12, 21, 22, 31, 41, 50, 53, 55, 56) . It is a process of both active removal and chemical degradation not confined to the implantation site (2, 24, 32, 65, 66) . The biochemical fate of phagocytized particles is probably of more importance than the fact of their ingestion by cells. As early as 1963, a study by Hollenberg et a1 (31) reported excretion of radiolabeled PU via the urine and feces of exposed animals, but it is not known whether the excreted material was particulate PU or a metabolite. A more recent case (14) reported detection of 2,4-diaminotoluene (DAT), a major in vitro hydrolysis product of PUS, in the urine of a woman bearing PU-covered implants. Various labs have claimed that both DAT and 4,4'-methylenedianiline (MDA), used in the manufacturing of the diisocyanate intermediates of PU foams, can be liberated from commercially available material by proteolytic enzyme digestion and acidic hydrolysis in vitro (1, 5, 20) . MDA is a potent human hepatotoxin (33, whereas DAT is known to be a hepatocarcinogen in the rat (16, 36) . The International Agency for Research on Cancer (IARC) has classified both compounds as possible human carcinogens (36, 37) . Such iiz vitro studies have often drawn criticism because of the artificial variables (e.g., strong adids or bases) employed. However, in vivo release of superoxide anion radicals, enzymes and hydrolases, especially over the course of prolonged inflammatory processes, result in acidic conditions (65) . More ominous are recent indications that DAT can also be produced in more neutral environments (42); polyesterurethane has been shown to degrade when exposed for some time to only water and high humidity (20), thus posing the possibility that even mild inflammatory reactions in the body may be sufficient for chemical degradation.
The suspicion that breakdown products are reaIity and have the potential to be systemically distributed has drawn more attention to the problem of detection. Scanning electron microscopy, transmission electron microscopy, energy dispersive x-ray analysis, and spectroscopy are more sensitive and accurate methods that have been used for monitoring the physical and chemical breakdown of implant biomaterials in the analytical laboratory (2, 20, 24, (63) (64) (65) (66) . These technologies have yielded new evidence that in vivo chemical degradation of PU does occur and is likely an oxidative process initiated and propelled by macrophages and foreign body giant cells (2, 65, 66) . At least 1 laboratory has described the development of monoclonal antibodies against DAT linked to tissue proteins and DNA (44) . Such immunohistochemical methods will allow testing of clinical specimens and body fluids, such as breast milk, for PU by-products. Local solid-state or foreign body carcinogenicity has long been the classic concern for all artificial implants. Depending on the form of material implanted and the specific site of implantation, PU did prove to be tumorigenic in the majority of early animal tests. Subcutaneous or intradermal exposures yielded sarcomas, while carcinomas and mesotheliomas were induced by intraperitoneal inoculation (3, 4, 7, 33, 34, 47, 51, 52) . PU foam proved to be as tumorigenic, ifnot more so, than the smoothsurfaced films and disks implicated by Oppenheimer and Nothdurft, as discussed in Bischoff and Bryson's review (7) , and later by . These early studies in foreign body/solid-state carcinogenesis did not address possible chemical interaction or particle migration between implant and tissue, focusing instead on the ability of a presumably inert material to stimulate the formation of a fibrous capsule believed to be the direct agent of site-specific tumorigenesis (8, 9, 47, 51, 52) . No evidence of mammary neoplasia or preneoplastic change was seen in either control or implant mice through the course of this study. The experiment may not have run long enough for tumorigenicity to occur; by general consensus, foreign body carcinogenesis is a process requiring a significant length oftime, sometimes une-half to two-thirds of an organism's lifespan, to  develop (8, 47, 52) . Alternatively, the chronic inflammatory state evoked by the PU may have interfered by maintaining high immunosurveillance.
Another possibility is that there may, in fact, have been carcinogenic degradation products released in those earlier studies and that mammary tissue is not as susceptible as the peritoneum or subcutis. We do not know much about xenobiotic metabolism in the breast, except that it is different from liver and kidney (39, 43) . Another factor to consider is that multiple new DAT and MDA metabolites have been idenrified via acetylation, which some researchers suggest to be the major activation route in the breast (25, 26, 61) .
Even though cancer was not a feature of our model, it continues to be the major concern in monitoring breast implant patients. It may turn out that surveys and implant registries are looking at the wrong organs at the wrong time. Perhaps the individual PU particles inside the mobile phagocytes are equally capable of initiating neoplasia outside the implant site. A 13 +-yr survey of breast implant recipients in California by Deapen (1 7) at the University of Southern California showed a 5-fold increase, not in breast cancers but in rare vulvular carcinomas. In rats and mice, experimentally administered DAT is excreted via the urine (28) . If PU and/or its degradation products are similarly eliminated, perhaps the urinary tract and external genitalia are at as much or more risk than breast tissue. We saw PU fibers in very close association to milk ducts in our lactating mice. Perhaps the breast-fed children of PU implant recipients also should be monitored. Even considering solid-state carcinogenesis, major stumbling blocks to the extrapolation of hazard in animals to hazards in humans are the questions of latency and susceptibility. The latency of a potentially tumorigenic implant could be expected to exceed the lifespan of the human recipient in her late 30s or older. However, cosmetic mammaplastic procedures are performed on increasingly younger women for whom latency becomes a pertinent issue (1 7, 29, 30) . In addition, until very recently, little to no thought was given to the possibility that women who have had breast replacement due to cancer or breast disease, as well as augmentation patients with a background of familial breast cancer, may represent a subcategory for which artificial implants and/or the surgical injury itself constitute a promotional event (45, 53, 57, 59, 60) .
Animal testing of biomaterials destined for use in mammaplastic procedures must be performed in female mammary sites. Experience reveals that we cannot rely on examination of anecdotal human data or historical and often widely variable experimental reports to predict, identify, or devise treatments,fqF adverse effects of breast implants. The present experiment was designed to refine and test an animal model that is suitable for investigation of the effects of human-made breast implant materials specifically in mammary tissue. In addition to confirming previous results by others using PU, the present study showed tissue responses in mice over time that are, in fact, analogous to those reported in women receiving PU-coated breast implants. Of significant importance is the chronic and subclinical inflammatory response and disappearance of the material encountered in both species. Further long-term studies using this model system are clearly necessary to delineate the ultimate fate of PU in the body as well as to test its potential toxicologic effects.
